Hong Kong, Hong Kong · Founded 2025 · Privately Held (backing)
Developer of RNA-based biopharmaceutical technologies intended to accelerate therapeutic innovation in precision medicine. ALLYRNA is based in Hong Kong, Hong Kong and was founded in 2025. It has raised $10 million.
Last price · $/share
—
Implied valuation
—
Total raised
$10.0M
Last round
—
Team — not yet on record
No current team members for ALLYRNA are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ALLYRNA with a free account
·Watch ALLYRNA: the Monday email on marks, rounds and moves
